4//SEC Filing
NEWLINK GENETICS CORP 4
Accession 0001126234-14-000070
CIK 0001126234operating
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:17 PM ET
Size
8.8 KB
Accession
0001126234-14-000070
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
LINK GORDON H JR
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2014-02-24$2.10/sh+8,500$17,850→ 24,813 total - Sale
Common Stock
2014-02-24$50.00/sh−8,500$425,000→ 16,313 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-02-24−8,500→ 56,239 totalExercise: $2.10Exp: 2018-08-05→ Common Stock (8,500 underlying)
Footnotes (3)
- [F1]Includes 5,700 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on January 2, 2015, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F2]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 7/29/2013.
- [F3]1/4th of the shares vest on August 4, 2009, which is one year after the vesting commencement date. 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
NEWLINK GENETICS CORP
CIK 0001126234
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001126234
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:17 PM ET
- Size
- 8.8 KB